Eivy F. B.
- Country
- Germany
- Department
- NA
Research Overview
- A phase IV randomised, double-blind, parallel-design, controlled multi-center trial of a NOVel moisturiser for Atopic dermatitis: effect on relapse prevention in children, NOVA II
- Randomized, Double-Blind Study on the Efficacy and Safety of Methylprednisolone Aceponate 0.1% Ointment in Mild to Moderate Atopic Dermatitis
- Phase III Study on Immunogenicity and Safety of MenACYW Conjugate Vaccine Versus Nimenrix in Healthy Infants and Toddlers
Data & Insights
Has run more than one trial at 6 of 82 partner sites.
Specializations
Pediatric Infectious Disease Prevention
This investigator specializes in meningococcal disease prevention in pediatric populations, with particular focus on vaccine immunogenicity among infants and toddlers.
- Infant vaccination protocols
- Long-term immune response monitoring
- Multi-strain vaccine development
The research extends to studying long-term immunity through booster vaccination strategies in children and adolescents.
Pediatric Dermatology
The investigator conducts research in pediatric atopic dermatitis treatment and management, focusing on preventive therapeutic approaches.
- Eczema relapse prevention
- Topical treatment evaluation
- Moisturizer efficacy studies
Their work involves evaluating innovative topical treatments for chronic skin conditions in children.
Vaccine Development
The investigator's expertise includes conjugate vaccine research with emphasis on quadrivalent meningococcal vaccines and their long-term effectiveness.
- Multi-year immunity assessment
- Booster response evaluation
- Safety profile monitoring
Their research encompasses vaccine safety and immunogenicity across different age groups and time intervals.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.